SEC Form 4 · accession 0001078274-19-000009
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven S Myers
Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 16, 2019 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | Jan 14, 2019 | A | 12,121 | $4.95 | A | 57,027 | D | |
| Common Stock | holding | — | — | — | 8,434 | I | By Steven S Myers IRA | |
| Common Stock | holding | — | — | — | 1,954 | I | By Steven S Myers Revocable Trust dated 12/1/2000 | |
| Common Stock | holding | — | — | — | 802 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 12,121 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 14, 2020.
- F2Includes 12,121 unvested restricted stock units.